Top Sell
Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals Inc. | 20 | 5 | 1 | 0 | €34.37 | €56.86 | 65.441% |
Fate Therapeutics Inc. | 4 | 3 | 1 | 0 | €3.25 | €8.27 | 154.345% |
Agenus Inc. | 4 | 2 | 1 | 0 | €0.41 | €36.85 | 8804.785% |
Evotec SE | 4 | 1 | 1 | 0 | €8.95 | €16.00 | 78.771% |
Fibrogen Inc. | 1 | 2 | 1 | 0 | €1.20 | €4.00 | 232.502% |
Gritstone Oncology Inc | 4 | 2 | 1 | 0 | €0.74 | €5.07 | 584.662% |
Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.58 | €3.00 | 419.931% |
Mirati Therapeutics Inc. | 2 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |
Revance Therapeutics Inc. | 0 | 2 | 0 | 1 | €2.50 | - | - |
Cyclacel Pharmaceuticals Inc. | 2 | 12 | 0 | 0 | €0.22 | €14.66 | 6565.591% |
Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.77 | €3.00 | 69.924% |
Karyopharm Therapeutics Inc. | 8 | 2 | 0 | 0 | €0.98 | €5.54 | 467.212% |
Inotiv Inc. | 3 | 1 | 0 | 0 | €1.86 | €10.66 | 473.210% |
Roche Holding AG ADR | 2 | 1 | 0 | 0 | €29.14 | €38.00 | 30.397% |
Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €6.40 | €58.50 | 814.063% |
Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | €1.42 | €1.20 | -15.493% |
Formycon AG | 3 | 1 | 0 | 0 | €42.00 | €100.00 | 138.095% |
NanoCarrier Co Ltd | 0 | 1 | 0 | 0 | €0.72 | - | - |
Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | €0.14 | - | - |
AEterna Zentaris Inc. | 3 | 18 | 0 | 0 | €1.87 | €14.02 | 649.759% |
Omeros Corp. | 2 | 4 | 0 | 0 | €3.08 | - | - |
Minerva Neurosciences Inc. | 0 | 6 | 0 | 1 | €2.30 | - | - |
Shin Nippon Biomedical Laboratories Ltd. | 0 | 1 | 0 | 0 | €7.45 | - | - |
Organovo Holdings Inc. | 0 | 7 | 0 | 0 | €0.92 | - | - |